en
Scientific article
French

[Rituximab-induced acute thrombocytopenia in a patient with chronic lymphocytic leukemia]

Published inLa Revue de médecine interne, vol. 38, no. 5, p. 344-346
Publication date2017
Abstract

Rituximab is a chimeric anti-CD20 monoclonal antibody generally well tolerated. However, a severe but rare rituximab-related immune-toxic syndrome, associating fever, chills and thrombocytopenia can occur shortly after the infusion.

Citation (ISO format)
BOBOT, M et al. [Rituximab-induced acute thrombocytopenia in a patient with chronic lymphocytic leukemia]. In: La Revue de médecine interne, 2017, vol. 38, n° 5, p. 344–346. doi: 10.1016/j.revmed.2016.08.008
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0248-8663
328views
0downloads

Technical informations

Creation11/09/2016 12:18:00 PM
First validation11/09/2016 12:18:00 PM
Update time03/15/2023 1:04:27 AM
Status update03/15/2023 1:04:26 AM
Last indexation01/16/2024 10:33:21 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack